Redefining Early Diagnosis: Quantitative Susceptibility Mapping at MRI Forecasts Onset of Mild Cognitive Impairment.

Radiology

Boston University, VA Boston Health Care System, Boston Medical Center, One Boston Medical Center Place, Boston, MA 02118.

Published: September 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.252398DOI Listing

Publication Analysis

Top Keywords

redefining early
4
early diagnosis
4
diagnosis quantitative
4
quantitative susceptibility
4
susceptibility mapping
4
mapping mri
4
mri forecasts
4
forecasts onset
4
onset mild
4
mild cognitive
4

Similar Publications

Wearable bioelectronics for skin cancer management.

Biomaterials

August 2025

Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, 90095, USA. Electronic address:

Wearable bioelectronics have transformed modern biomedical applications by enabling seamless integration with biological tissues, providing continuous, comprehensive, and personalized healthcare. Skin cancer, particularly melanoma, poses a significant clinical challenge due to its high metastatic potential and associated mortality. Traditional diagnostic approaches face limitations in accuracy, accessibility, and reproducibility, while existing treatments are often constrained by systemic toxicity and therapeutic resistance.

View Article and Find Full Text PDF

Ingestible biosensors for drug delivery monitoring.

Prog Mol Biol Transl Sci

September 2025

School of Forensic Science, National Forensic Sciences University, Gandhinagar, Gujarat, India.

Ingestible biosensors are a mix of advanced biomedical engineering, digital health and precision pharmacotherapy. These miniaturised electronic devices are encapsulated in biocompatible materials, which operate within gastrointestinal (GI) tract. This enables real-time monitoring of pharmacological and physiological parameters.

View Article and Find Full Text PDF

Artificial intelligence is revolutionizing health care, particularly in precision medicine and noninvasive diagnostics. Anemia, which is a widespread condition that affects billions of people worldwide, compromises oxygen transport due to low hemoglobin levels, which leads to severe complications if left undetected. Early and frequent monitoring is essential, yet traditional blood tests can be invasive, costly, and impractical for continuous assessment.

View Article and Find Full Text PDF

Biliverdin reductase-A is a key modulator in insulin signaling and metabolism.

Trends Endocrinol Metab

September 2025

Department of Biochemical Sciences 'A. Rossi-Fanelli, ' Sapienza University of Rome, Piazzale A. Moro 5, 00185, Rome, Italy. Electronic address:

Biliverdin reductase-A (BVRA) is a pleiotropic enzyme traditionally known for its antioxidant role in the heme degradation pathway. Recent findings have redefined BVRA as a master regulator of insulin signaling, acting as a kinase, scaffold, and redox-sensitive integrator of metabolic cues. BVRA modulates key nodes of the insulin cascade and sustains mitochondrial and synaptic function.

View Article and Find Full Text PDF